Position in LLY
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$609,310
+$150,345 QoQ
Shares Held
508
+1.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#3,587
of 4,605 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Nautilus Advisors LLC holds $5,916,229 across 6 Drug Manufacturers - General names. LLY ranks #6 (10.3% of the industry book) .
All Filings in LLY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $609,310 | 508 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $458,965 | 499 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $531,966 | 495 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $377,685 | 495 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $385,867 | 495 | Shares | Sole | 2025-08-26 | |
| 2025-03-31 | $407,999 | 494 | Shares | Sole | 2025-08-26 | |
| 2024-12-31 | $381,368 | 494 | Shares | Sole | 2025-08-26 | |
| No filing history on record for this holder in this stock. | ||||||